<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> has to be drastically controlled in organs with important cell turnover such as the colon </plain></SENT>
<SENT sid="1" pm="."><plain>Deregulation of this process is often present in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Tissues of 82 patients treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) were analyzed using antibodies against AIF, p53, DR4, DR5, cleaved caspase-3 and the TUNEL method to detect <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; whereas staining of Ki-67 was used as a proliferation marker </plain></SENT>
<SENT sid="3" pm="."><plain>In situ immunohistochemical analyses were compared in non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (NT) cells from <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent mucous membranes with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (T) cells from patients with Stage I (n=6), Stage II (n=35), Stage III (n=27) and Stage IV (n=14) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Results were correlated with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stages and the treatment response of patients to improve the understanding of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development </plain></SENT>
<SENT sid="5" pm="."><plain>p53 and DR5 expression decreased progressively with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> stage, suggesting that these proteins are important markers of advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stages </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, p53 appears as a prognostic factor to predict recurrence-free survival </plain></SENT>
<SENT sid="7" pm="."><plain>Including the detection of p53 and DR5 for establishing the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and adapting the treatment to each patient is strongly suggested by our work </plain></SENT>
</text></document>